HNF4A and type 2 diabetes mellitus: Using two mouse models of T2D, we demonstrate that metformin enhances hepatic redox and inhibits HGP, at least in part, via activating an evolutionarily conserved regulatory pathway encompassing let-7 and TET3/HNF4α-P2 (Fig. 1N).